News
In its first-quarter 2025 investor letter, TimesSquare Capital U.S. Focus Growth Strategy highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products ...
CONSHOHOCKEN, Pa., May 28, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1 ...
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1, 2025.
CONSHOHOCKEN, Pa. - Cencora, Inc. (NYSE: COR), a global pharmaceutical solutions provider with a market capitalization of $56.87 billion, announced the appointment of Lori J. Ryerkerk to its Board ...
Shares of Cencora Inc. COR shed 1.43% to $289.19 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.56% to 5,888.55 and ...
In this article, we are going to take a look at where Cramer noted that while Cencora, Inc. (NYSE:COR) stands against other stocks that Jim Cramer discussed recently. On Wednesday’s episode of ...
Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #2 ...
I’ve never been a big Reels guy on Instagram. Sure, I’ll spend far too long scrolling through them here and there, but I rarely try my hand at making one. After all, as a photographer for my l ...
We recently published a list of 8 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at where Cramer noted that while Cencora, Inc. (NYSE:COR) stands against other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results